NICE backs use of Opdivo for lung cancer

20th September 2017 Uncategorised 0

Bristol-Myers Squibb’s Opdivo is being recommended by the National Institute for Health and Care Excellence to treat a certain form of lung cancer on the NHS in England, via the Cancer Drugs Fund.

More: NICE backs use of Opdivo for lung cancer
Source: News